Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy.

Mahmud M, Pinnschmidt HO, Reinhard L, Harendza S, Wiech T, Stahl RAK, Hoxha E.

PLoS One. 2019 Sep 9;14(9):e0221293. doi: 10.1371/journal.pone.0221293. eCollection 2019.

2.

Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies.

Irmscher S, Brix SR, Zipfel SLH, Halder LD, Mutlutürk S, Wulf S, Girdauskas E, Reichenspurner H, Stahl RAK, Jungnickel B, Wiech T, Zipfel PF, Skerka C.

Nat Commun. 2019 Jul 4;10(1):2961. doi: 10.1038/s41467-019-10766-0.

3.

The authors reply.

Brix SR, Huber TB, Waldherr R, Hopfer H, Stahl RAK, Wiech T.

Kidney Int. 2019 Jul;96(1):245-246. doi: 10.1016/j.kint.2019.01.048. No abstract available.

PMID:
31229032
4.

Diagnostic role of renal biopsy in PLA2R1-antibody-positive patients with nephrotic syndrome.

Wiech T, Stahl RAK, Hoxha E.

Mod Pathol. 2019 Sep;32(9):1320-1328. doi: 10.1038/s41379-019-0267-z. Epub 2019 Apr 8.

PMID:
30962506
5.

[Membranous glomerulonephritis : An example of individualized medicine in nephrology].

Stahl RAK, Hoxha E.

Internist (Berl). 2019 May;60(5):440-449. doi: 10.1007/s00108-019-0573-z. Review. German.

PMID:
30859275
6.

Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.

von Haxthausen F, Reinhard L, Pinnschmidt HO, Rink M, Soave A, Hoxha E, Stahl RAK.

Front Immunol. 2018 Dec 20;9:3035. doi: 10.3389/fimmu.2018.03035. eCollection 2018.

7.

Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.

Stahl RA, Reinhard L, Hoxha E.

Expert Rev Clin Immunol. 2019 Feb;15(2):165-175. doi: 10.1080/1744666X.2019.1548934. Epub 2018 Nov 27.

PMID:
30433832
8.

Development and validation of a renal risk score in ANCA-associated glomerulonephritis.

Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M, Jabs WJ, Özcan F, Wendt R, Hausberg M, Sellin L, Panzer U, Huber TB, Waldherr R, Hopfer H, Stahl RAK, Wiech T.

Kidney Int. 2018 Dec;94(6):1177-1188. doi: 10.1016/j.kint.2018.07.020. Epub 2018 Oct 29.

PMID:
30385041
9.

The chemokine receptor CX3CR1 reduces renal injury in mice with angiotensin II-induced hypertension.

Ahadzadeh E, Rosendahl A, Czesla D, Steffens P, Prüßner L, Meyer-Schwesinger C, Wanner N, Paust HJ, Huber TB, Stahl RAK, Wiech T, Kurts C, Seniuk A, Ehmke H, Wenzel UO.

Am J Physiol Renal Physiol. 2018 Dec 1;315(6):F1526-F1535. doi: 10.1152/ajprenal.00149.2018. Epub 2018 Sep 12.

PMID:
30207169
10.

IL-10 Receptor Signaling Empowers Regulatory T Cells to Control Th17 Responses and Protect from GN.

Diefenhardt P, Nosko A, Kluger MA, Richter JV, Wegscheid C, Kobayashi Y, Tiegs G, Huber S, Flavell RA, Stahl RAK, Steinmetz OM.

J Am Soc Nephrol. 2018 Jul;29(7):1825-1837. doi: 10.1681/ASN.2017091044. Epub 2018 Jun 4.

11.

The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.

Seifert L, Hoxha E, Eichhoff AM, Zahner G, Dehde S, Reinhard L, Koch-Nolte F, Stahl RAK, Tomas NM.

J Am Soc Nephrol. 2018 May;29(5):1536-1548. doi: 10.1681/ASN.2017070805. Epub 2018 Mar 19.

12.

IL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation.

Krohn S, Nies JF, Kapffer S, Schmidt T, Riedel JH, Kaffke A, Peters A, Borchers A, Steinmetz OM, Krebs CF, Turner JE, Brix SR, Paust HJ, Stahl RAK, Panzer U.

J Am Soc Nephrol. 2018 Apr;29(4):1210-1222. doi: 10.1681/ASN.2017090949. Epub 2018 Feb 26.

13.

Organisation of lymphocytic infiltrates in ANCA-associated glomerulonephritis.

Brix SR, Noriega M, Herden EM, Goldmann B, Langbehn U, Busch M, Jabs WJ, Steinmetz OM, Panzer U, Huber TB, Stahl RAK, Wiech T.

Histopathology. 2018 Jun;72(7):1093-1101. doi: 10.1111/his.13487. Epub 2018 Mar 25.

PMID:
29453894
14.

Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents.

Dettmar AK, Wiech T, Kemper MJ, Soave A, Rink M, Oh J, Stahl RAK, Hoxha E; Pediatric MN Study Group.

Pediatr Nephrol. 2018 Mar;33(3):463-472. doi: 10.1007/s00467-017-3817-y. Epub 2017 Oct 15.

PMID:
29034405
15.

Translational Aspects of Primary Membranous Nephropathy.

Hoxha E, Stahl RAK.

Semin Nephrol. 2017 Sep;37(5):436-446. doi: 10.1016/j.semnephrol.2017.05.017. Review.

PMID:
28863791
16.

A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy.

Tomas NM, Meyer-Schwesinger C, von Spiegel H, Kotb AM, Zahner G, Hoxha E, Helmchen U, Endlich N, Koch-Nolte F, Stahl RAK.

J Am Soc Nephrol. 2017 Nov;28(11):3262-3277. doi: 10.1681/ASN.2017010030. Epub 2017 Aug 16.

17.

Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.

Radón V, Czesla M, Reichelt J, Fehlert J, Hammel A, Rosendahl A, Knop JH, Wiech T, Wenzel UO, Sachs M, Reinicke AT, Stahl RAK, Meyer-Schwesinger C.

Kidney Int. 2018 Jan;93(1):110-127. doi: 10.1016/j.kint.2017.05.016. Epub 2017 Jul 26.

PMID:
28754552
18.

Membranous nephropathy-one morphologic pattern with different diseases.

Hoxha E, von Haxthausen F, Wiech T, Stahl RAK.

Pflugers Arch. 2017 Aug;469(7-8):989-996. doi: 10.1007/s00424-017-2000-4. Epub 2017 May 29. Review.

PMID:
28555350
19.

IL-33-Mediated Expansion of Type 2 Innate Lymphoid Cells Protects from Progressive Glomerulosclerosis.

Riedel JH, Becker M, Kopp K, Düster M, Brix SR, Meyer-Schwesinger C, Kluth LA, Gnirck AC, Attar M, Krohn S, Fehse B, Stahl RAK, Panzer U, Turner JE.

J Am Soc Nephrol. 2017 Jul;28(7):2068-2080. doi: 10.1681/ASN.2016080877. Epub 2017 Feb 2.

20.

THSD7A expression in human cancer.

Stahl PR, Hoxha E, Wiech T, Schröder C, Simon R, Stahl RA.

Genes Chromosomes Cancer. 2017 Apr;56(4):314-327. doi: 10.1002/gcc.22440. Epub 2017 Feb 6.

PMID:
28035718
21.

RORγt expression in Tregs promotes systemic lupus erythematosus via IL-17 secretion, alteration of Treg phenotype and suppression of Th2 responses.

Kluger MA, Nosko A, Ramcke T, Goerke B, Meyer MC, Wegscheid C, Luig M, Tiegs G, Stahl RA, Steinmetz OM.

Clin Exp Immunol. 2017 Apr;188(1):63-78. doi: 10.1111/cei.12905. Epub 2017 Jan 5.

22.

Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney.

Krebs CF, Paust HJ, Krohn S, Koyro T, Brix SR, Riedel JH, Bartsch P, Wiech T, Meyer-Schwesinger C, Huang J, Fischer N, Busch P, Mittrücker HW, Steinhoff U, Stockinger B, Perez LG, Wenzel UO, Janneck M, Steinmetz OM, Gagliani N, Stahl RAK, Huber S, Turner JE, Panzer U.

Immunity. 2016 Nov 15;45(5):1078-1092. doi: 10.1016/j.immuni.2016.10.020.

23.

Disseminated Mycobacterium haemophilum infection in a renal transplant recipient.

Brix SR, Iking-Konert C, Stahl RA, Wenzel U.

BMJ Case Rep. 2016 Oct 31;2016. pii: bcr2016216042. doi: 10.1136/bcr-2016-216042.

24.

Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome.

Beneke J, Sartison A, Kielstein JT, Haller H, Nitschke M, Kunzendorf U, Loos S, Kemper MJ, Stahl RA, Menne J; German 2011 STEC-HUS outbreak study group.

Transfus Med Rev. 2017 Jan;31(1):51-55. doi: 10.1016/j.tmrv.2016.06.004. Epub 2016 Jun 21.

PMID:
27468945
25.

An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.

Hoxha E, Beck LH Jr, Wiech T, Tomas NM, Probst C, Mindorf S, Meyer-Schwesinger C, Zahner G, Stahl PR, Schöpper R, Panzer U, Harendza S, Helmchen U, Salant DJ, Stahl RA.

J Am Soc Nephrol. 2017 Feb;28(2):520-531. doi: 10.1681/ASN.2016010050. Epub 2016 Jul 19.

26.

[Glomerulonephritis].

Stahl RA, Hoxha E.

Dtsch Med Wochenschr. 2016 Jul;141(13):960-8. doi: 10.1055/s-0042-107410. Epub 2016 Jun 30. Review. German.

PMID:
27359316
27.

T-Bet Enhances Regulatory T Cell Fitness and Directs Control of Th1 Responses in Crescentic GN.

Nosko A, Kluger MA, Diefenhardt P, Melderis S, Wegscheid C, Tiegs G, Stahl RA, Panzer U, Steinmetz OM.

J Am Soc Nephrol. 2017 Jan;28(1):185-196. doi: 10.1681/ASN.2015070820. Epub 2016 Jun 13.

28.

Plasticity of Th17 Cells in Autoimmune Kidney Diseases.

Krebs CF, Turner JE, Paust HJ, Kapffer S, Koyro T, Krohn S, Ufer F, Friese MA, Flavell RA, Stockinger B, Steinmetz OM, Stahl RA, Huber S, Panzer U.

J Immunol. 2016 Jul 15;197(2):449-57. doi: 10.4049/jimmunol.1501831. Epub 2016 Jun 6.

29.

Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.

Tomas NM, Hoxha E, Reinicke AT, Fester L, Helmchen U, Gerth J, Bachmann F, Budde K, Koch-Nolte F, Zahner G, Rune G, Lambeau G, Meyer-Schwesinger C, Stahl RA.

J Clin Invest. 2016 Jul 1;126(7):2519-32. doi: 10.1172/JCI85265. Epub 2016 May 23.

30.

A Mechanism for Cancer-Associated Membranous Nephropathy.

Hoxha E, Wiech T, Stahl PR, Zahner G, Tomas NM, Meyer-Schwesinger C, Wenzel U, Janneck M, Steinmetz OM, Panzer U, Harendza S, Stahl RA.

N Engl J Med. 2016 May 19;374(20):1995-6. doi: 10.1056/NEJMc1511702. No abstract available.

PMID:
27192690
31.

The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension.

Weiss S, Rosendahl A, Czesla D, Meyer-Schwesinger C, Stahl RA, Ehmke H, Kurts C, Zipfel PF, Köhl J, Wenzel UO.

Am J Physiol Renal Physiol. 2016 Jun 1;310(11):F1356-65. doi: 10.1152/ajprenal.00040.2016. Epub 2016 Apr 6.

32.

IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases.

Riedel JH, Paust HJ, Krohn S, Turner JE, Kluger MA, Steinmetz OM, Krebs CF, Stahl RA, Panzer U.

J Am Soc Nephrol. 2016 Dec;27(12):3666-3677. Epub 2016 Mar 30.

33.

CXCR3+ Regulatory T Cells Control TH1 Responses in Crescentic GN.

Paust HJ, Riedel JH, Krebs CF, Turner JE, Brix SR, Krohn S, Velden J, Wiech T, Kaffke A, Peters A, Bennstein SB, Kapffer S, Meyer-Schwesinger C, Wegscheid C, Tiegs G, Thaiss F, Mittrücker HW, Steinmetz OM, Stahl RA, Panzer U.

J Am Soc Nephrol. 2016 Jul;27(7):1933-42. doi: 10.1681/ASN.2015020203. Epub 2015 Nov 3.

34.

Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus.

Kluger MA, Melderis S, Nosko A, Goerke B, Luig M, Meyer MC, Turner JE, Meyer-Schwesinger C, Wegscheid C, Tiegs G, Stahl RA, Panzer U, Steinmetz OM.

Kidney Int. 2016 Jan;89(1):158-66. doi: 10.1038/ki.2015.296. Epub 2016 Jan 4.

PMID:
26466322
35.

Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy.

Hoxha E, Harendza S, Pinnschmidt HO, Tomas NM, Helmchen U, Panzer U, Stahl RA.

Nephrol Dial Transplant. 2015 Nov;30(11):1862-9. doi: 10.1093/ndt/gfv228. Epub 2015 Jul 3.

PMID:
26142398
36.

Membranous Nephropathy: The Journey Continues ….

Hoxha E, Stahl RA.

EBioMedicine. 2015 Mar 18;2(5):374-5. doi: 10.1016/j.ebiom.2015.03.013. eCollection 2015 May. No abstract available.

37.

RORγt(+)Foxp3(+) Cells are an Independent Bifunctional Regulatory T Cell Lineage and Mediate Crescentic GN.

Kluger MA, Meyer MC, Nosko A, Goerke B, Luig M, Wegscheid C, Tiegs G, Stahl RA, Panzer U, Steinmetz OM.

J Am Soc Nephrol. 2016 Feb;27(2):454-65. doi: 10.1681/ASN.2014090880. Epub 2015 Jun 8.

38.

CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN.

Brix SR, Stege G, Disteldorf E, Hoxha E, Krebs C, Krohn S, Otto B, Klätschke K, Herden E, Heymann F, Lira SA, Tacke F, Wolf G, Busch M, Jabs WJ, Özcan F, Keller F, Beige J, Wagner K, Helmchen U, Noriega M, Wiech T, Panzer U, Stahl RA.

J Am Soc Nephrol. 2015 Sep;26(9):2105-17. doi: 10.1681/ASN.2014040407. Epub 2015 Mar 11.

39.

Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.

Meyer-Schwesinger C, Lambeau G, Stahl RA.

N Engl J Med. 2015 Mar 12;372(11):1074-5. doi: 10.1056/NEJMc1500130. No abstract available.

PMID:
25760364
40.

Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN.

Luig M, Kluger MA, Goerke B, Meyer M, Nosko A, Yan I, Scheller J, Mittrücker HW, Rose-John S, Stahl RA, Panzer U, Steinmetz OM.

J Am Soc Nephrol. 2015 Jul;26(7):1597-607. doi: 10.1681/ASN.2014060620. Epub 2015 Feb 5.

41.

Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.

Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U, Dabert-Gay AS, Debayle D, Merchant M, Klein J, Salant DJ, Stahl RAK, Lambeau G.

N Engl J Med. 2014 Dec 11;371(24):2277-2287. doi: 10.1056/NEJMoa1409354. Epub 2014 Nov 13.

42.

Function of the Th17/interleukin-17A immune response in murine lupus nephritis.

Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, Koyro T, Peters A, Velden J, Hünemörder S, Haag F, Steinmetz OM, Mittrücker HW, Stahl RA, Panzer U.

Arthritis Rheumatol. 2015 Feb;67(2):475-87. doi: 10.1002/art.38955.

43.

PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.

Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RA.

PLoS One. 2014 Oct 14;9(10):e110681. doi: 10.1371/journal.pone.0110681. eCollection 2014.

44.

MicroRNA-193a Regulates the Transdifferentiation of Human Parietal Epithelial Cells toward a Podocyte Phenotype.

Kietzmann L, Guhr SS, Meyer TN, Ni L, Sachs M, Panzer U, Stahl RA, Saleem MA, Kerjaschki D, Gebeshuber CA, Meyer-Schwesinger C.

J Am Soc Nephrol. 2015 Jun;26(6):1389-401. doi: 10.1681/ASN.2014020190. Epub 2014 Sep 30.

45.

M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.

Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RA.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1883-90. doi: 10.2215/CJN.03850414. Epub 2014 Sep 29.

46.

Neuropsychological outcome after complicated Shiga toxin-producing Escherichia coli infection.

Simova O, Weineck G, Schuetze T, Wegscheider K, Panzer U, Stahl RA, Gerloff C, Magnus T.

PLoS One. 2014 Jul 22;9(7):e103029. doi: 10.1371/journal.pone.0103029. eCollection 2014.

47.

[Membranous nephropathy--crucial developments for diagnostic and treatment].

Stahl RA, Harendza S, Helmchen U, Hoxha E.

Dtsch Med Wochenschr. 2014 Jul;139(27):1433-6. doi: 10.1055/s-0034-1370136. Epub 2014 Jun 17. German. No abstract available.

PMID:
24937082
48.

CXCL5 drives neutrophil recruitment in TH17-mediated GN.

Disteldorf EM, Krebs CF, Paust HJ, Turner JE, Nouailles G, Tittel A, Meyer-Schwesinger C, Stege G, Brix S, Velden J, Wiech T, Helmchen U, Steinmetz OM, Peters A, Bennstein SB, Kaffke A, Llanto C, Lira SA, Mittrücker HW, Stahl RA, Kurts C, Kaufmann SH, Panzer U.

J Am Soc Nephrol. 2015 Jan;26(1):55-66. doi: 10.1681/ASN.2013101061. Epub 2014 Jun 5.

49.

Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases.

Beeken M, Lindenmeyer MT, Blattner SM, Radón V, Oh J, Meyer TN, Hildebrand D, Schlüter H, Reinicke AT, Knop JH, Vivekanandan-Giri A, Münster S, Sachs M, Wiech T, Pennathur S, Cohen CD, Kretzler M, Stahl RA, Meyer-Schwesinger C.

J Am Soc Nephrol. 2014 Nov;25(11):2511-25. doi: 10.1681/ASN.2013050522. Epub 2014 Apr 10.

50.

Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.

Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RA.

J Am Soc Nephrol. 2014 Jun;25(6):1357-66. doi: 10.1681/ASN.2013040430. Epub 2014 Mar 7.

Supplemental Content

Loading ...
Support Center